Furthermore, analysis of human NSCLC databases and clinical specimens confirmed the association of the AR/circ-SLCO1B7/miR-139-5p/TPD52 signaling pathway with NSCLC progression. This evidence concerns the gene SLCO1B7 and non-small cell lung carcinoma.